| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.256 | 2.019 | 25.236 | 55.889 | 69.135 | 73.505 | 71.848 | 69.045 | 78.088 | 90.044 |
| Total Income - EUR | 2.256 | 2.019 | 25.395 | 56.243 | 69.319 | 75.586 | 71.986 | 69.130 | 78.108 | 90.050 |
| Total Expenses - EUR | 5.753 | 5.943 | 8.886 | 34.031 | 30.388 | 33.949 | 36.242 | 37.480 | 44.928 | 55.859 |
| Gross Profit/Loss - EUR | -3.496 | -3.924 | 16.509 | 22.213 | 38.931 | 41.637 | 35.744 | 31.651 | 33.180 | 34.192 |
| Net Profit/Loss - EUR | -3.564 | -3.972 | 16.013 | 21.650 | 38.238 | 40.936 | 35.038 | 31.045 | 32.415 | 31.544 |
| Employees | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Danador Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 20.627 | 16.160 | 11.801 | 18.955 | 12.849 | 7.798 | 4.899 | 2.110 |
| Current Assets | 26.981 | 20.261 | 31.221 | 52.947 | 84.028 | 106.347 | 35.640 | 62.698 | 22.077 | 35.917 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.523 | 1.507 | 4.349 | 2.874 | 4.497 | 4.541 | 5.340 | 6.816 | 12.612 | 30.532 |
| Cash | 25.458 | 18.753 | 26.871 | 50.073 | 79.531 | 101.806 | 30.300 | 55.881 | 9.465 | 5.385 |
| Shareholders Funds | 25.395 | 18.820 | 34.514 | 55.531 | 86.038 | 107.934 | 35.087 | 66.240 | 16.156 | 31.593 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.587 | 1.441 | 17.481 | 13.769 | 9.987 | 17.748 | 13.922 | 4.705 | 11.426 | 6.994 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Danador Med S.r.l.